Marina Biotech (MRNAD) Closes $5M Equity Investment, Will File Shelf Registration

Marina Biotech, Inc. (Nasdaq: MRNAD), has completed the closing of the previously announced equity investment of up to $5 million with Socius CG II, Ltd., a Bermuda-based subsidiary of Socius Capital Group, LLC, and will be filing a registration statement on Form S-3 to register the shares for resale by Socius. Once the S-3 is filed and declared effective by the U. S. Securities and Exchange Commission, and subject to the satisfaction of the other conditions set forth in the Securities Purchase Agreement between the Company and Socius, the funds available under the agreement will be accessible by the Company.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• enVVeno Medical (NVNO) files $100M mixed shelf
• Aveanna selling stockholders launch 15M share secondary offering
• Gray Media closes $750M note offering to refinance higher-rate debt